Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 2821 AL 2835

Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings

Blennow K, Zetterberg H.

Prog Mol Biol Transl Sci. 2019;168:3-23. doi: 10.1016/bs.pmbts.2019.07.006. Epub 2019 Jul 24.

The Potential Emergence of Disease-Modifying Treatments for Alzheimer Disease: The Role of Primary Care in Managing the Patient Journey

Lam J, Hlávka J, Mattke S.

J Am Board Fam Med. 2019 Nov-Dec;32(6):931-940. doi: 10.3122/jabfm.2019.06.180328.

Genetic Markers of Alzheimer's Disease

Nikolac Perkovic M, Pivac N.

Adv Exp Med Biol. 2019;1192:27-52. doi: 10.1007/978-981-32-9721-0_3.

Neutral Endopeptidase (Neprilysin) in Therapy and Diagnostics: Yin and Yang

Feygina EE, Katrukha AG, Semenov AG.

Biochemistry (Mosc). 2019 Nov;84(11):1346-1358. doi: 10.1134/S0006297919110105.

Functional Connectivity in Neurodegenerative Disorders: Alzheimer's Disease and Frontotemporal Dementia

Jalilianhasanpour R, Beheshtian E, Sherbaf G, Sahraian S, Sair HI.

Top Magn Reson Imaging. 2019 Dec;28(6):317-324. doi: 10.1097/RMR.0000000000000223.

A cerebrospinal fluid biosignature for the diagnosis of Alzheimer's disease

Barichello T, Giridharan VV, Dal-Pizzol F.

Braz J Psychiatry. 2019 Nov-Dec;41(6):467-468. doi: 10.1590/1516-4446-2019-0629.

Dementia is not synonymous with Alzheimer's disease

Jack CR Jr, Holtzman DM, Sperling R.

Sci Transl Med. 2019 Dec 11;11(522):eaav0511. doi: 10.1126/scitranslmed.aav0511.

Deep learning to detect Alzheimer's disease from neuroimaging: A systematic literature review

Ebrahimighahnavieh MA, Luo S, Chiong R.

Comput Methods Programs Biomed. 2020 Apr;187:105242. doi: 10.1016/j.cmpb.2019.105242. Epub 2019 Nov 27.

Advances and considerations in AD tau-targeted immunotherapy

Bittar A, Bhatt N, Kayed R.

Neurobiol Dis. 2020 Feb;134:104707. doi: 10.1016/j.nbd.2019.104707. Epub 2019 Dec 10.

Evaluating the reliability of neurocognitive biomarkers of neurodegenerative diseases across countries: A machine learning approach

Bachli MB, Sedeño L, Ochab JK, Piguet O, Kumfor F, Reyes P, Torralva T, Roca M, Cardona JF, Campo CG, Herrera E, Slachevsky A, Matallana D, Manes F, García AM, Ibáñez A, Chialvo DR.

Neuroimage. 2020 Mar;208:116456. doi: 10.1016/j.neuroimage.2019.116456. Epub 2019 Dec 10.

Biomarkers for Alzheimer's disease. Where we stand and where we are headed

Chrem Mendez P, Surace E, Bérgamo Y, Calandri I, Vázquez S, Sevlever G, Allegri RF.

Medicina (B Aires). 2019;79(Spec 6/1):546-551.

Applications of biosensors in Alzheimer's disease diagnosis

Brazaca LC, Sampaio I, Zucolotto V, Janegitz BC.

Talanta. 2020 Apr 1;210:120644. doi: 10.1016/j.talanta.2019.120644. Epub 2019 Dec 12.

[Alzheimer dementia: course and burden on caregivers : Data over 18 months from German participants of the GERAS study]

Hager K, Henneges C, Schneider E, Lieb M, Kraemer S.

Nervenarzt. 2018 Apr;89(4):431-442. doi: 10.1007/s00115-017-0371-6.

EEG and ERP biomarkers of Alzheimer's disease: a critical review

Horvath A, Szucs A, Csukly G, Sakovics A, Stefanics G, Kamondi A.

Front Biosci (Landmark Ed). 2018 Jan 1;23(2):183-220. doi: 10.2741/4587.

Medical imaging diagnosis of early Alzheimer's disease

A El-Gamal FE, Elmogy MM, Ghazal M, Atwan A, Casanova MF, Barnes GN, El-Baz A, Hajjdiab H.

Front Biosci (Landmark Ed). 2018 Jan 1;23(4):671-725. doi: 10.2741/4612.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias